Table 1. Clinical input parameters: short-term and long-term outcomes following SAVR/TAVI.
| Parameters | Value (range) | References | |
| SAVR | TAVI | ||
| SAVR: surgical aortic valve replacement; TAVI: transcatheter aortic valve implantation. | |||
| 30-day outcomes | |||
| Mortality | 0.0324 (0.0292-0.0356) | 0.0307 (0.0276-0.0338) | Makkar, et al [36], Reardon, et al [7], Adams, et al [21] |
| Stroke | 0.0321 (0.0289-0.0353) | 0.0447 (0.0403-0.0492) | |
| No complication | 0.1083 (0.0975-0.1192) |
0.4978 (0.4480-0.5476) | |
| 1-year outcomes | |||
| Mortality | 0.1108 (0.0997-0.1218) | 0.0984 (0.0886-0.1083) | Reardon, et al [7], Adams, et al [21], Leon, et al [6] |
| Stroke | 0.0334 (0.0300-0.0367) | 0.0253 (0.0228-0.0278) | |
| Vascular complications | 0.0308 (0.0277-0.0339) | 0.0554 (0.0498-0.0609) | |
| Major bleeding | 0.3918 (0.3526-0.4309) | 0.1626 (0.1463-0.1789) | |
| Acute kidney injury | 0.0495 (0.0446-0.0545) | 0.0276 (0.0248-0.0304) | |
| Atrial fibrillation | 0.2489 (0.2240-0.2738) | 0.0901 (0.0811-0.0992) | |
| Pacemaker implantation | 0.0595 (0.0535-0.0654) | 0.1345 (0.1211-0.1480) | |
| 2-year outcomes | |||
| Mortality | 0.0744 (0.0669-0.0818) | 0.0729 (0.0656-0.0801) | Makkar, et al [36], Reardon, et al [7], Adams, et al [21] |
| Stroke | 0.0269 (0.0242-0.0296) | 0.0210 (0.0189-0.0231) | |
| Vascular complications | 0.0273 (0.0246-0.0301) | 0.0435 (0.0391-0.0478) | |
| Major bleeding | 0.2660 (0.2394-0.2926) | 0.0874 (0.0787-0.0962) | |
| Acute kidney injury | 0.0283 (0.0255-0.0311) | 0.0180 (0.0162-0.0198) | |
| Atrial fibrillation | 0.1452 (0.1307-0.1597) | 0.0570 (0.0513-0.0627) | |
| Pacemaker implantation | 0.0487 (0.0438-0.0539) | 0.0581 (0.0523-0.0639) | |